lawsuit issue increased Baht 1.28 million. Loss Attributable to Equity Holders of the Company In 2019, there was a loss attributable to equity holders of the company of Baht 277.59 million, whereas Baht
%. Mainly from the revenues of booking and contracts cancellation. Nevertheless, the revenues from the property management was increased which correspond to the increase of project under company’s management
that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of
revenue or THB 328mn decreasing by 1.5% YoY. Cost of sales decreased from THB 482mn to THB 466mn or THB 16mn due to the exercise of assets optimisation in the last quarter. Cost-to-sales ratio increased
operating result in 3Q2020, the total transaction amount was Bt9,987mn, increasing 10.1% QoQ. The total usage amount increased from both top up and payment services by bt6,895mn. and the money transfer
consolidated financial statements for the same period of the year 2016, DCORP’s net loss increased by Baht 120.28 million. This was mainly due to setting a provision and amortization of Baht 42.73 million for
consolidated financial statements for the same period of the year 2016, DCORP’s net loss increased by Baht 120.28 million. This was mainly due to setting a provision and amortization of Baht 42.73 million for
site. In the first phase, the Company has space of usage approximately 9,800 sq.m2. for increased stock and new product in the retail group that responds to customers e.g. galvanized paints and etc
an increasing of cost of rental and services. Financial Cost The Company financial cost in 2018 was 63.0 million baht, which was higher than 2017 of 9.4 million baht or 1.3%. Financial cost increased
loss rate increased from the year 2018 due to the decrease of the total revenue of the company while having higher administrative expenses as mentioned above. Financial Statement for the ended of 30